Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zhenxin Zhang, Jian Wang, Xiaoying Zhang, Shengdi Chen, Zhenfu Wang, Baorong Zhang, Chunfeng Liu, Qiumin Qu, Yan Cheng, Rongxuan Zhu, Jie Li, Jingqiu Hu & Meng Cai. (2015) An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson’s disease. Current Medical Research and Opinion 31:4, pages 723-730.
Read now
Read now
James K Sheffield & Joseph Jankovic. (2007) Botulinum toxin in the treatment of tremors, dystonias, sialorrhea and other symptoms associated with Parkinson’s disease. Expert Review of Neurotherapeutics 7:6, pages 637-647.
Read now
Read now
Christopher Kenney & Joseph Jankovic. (2007) Rotigotine transdermal patch in the treatment of Parkinson’s disease and restless legs syndrome. Expert Opinion on Pharmacotherapy 8:9, pages 1329-1335.
Read now
Read now
Articles from other publishers (33)
Melanie R. Shackleford, Virendra Mishra & Zoltan Mari. (2022) Levodopa-Carbidopa Intestinal Gel may improve treatment-resistant freezing of gait in Parkinson’s disease. Clinical Parkinsonism & Related Disorders 7, pages 100148.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1095
1143
.
Raja Mehanna & Joseph Jankovic. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
48
.
Seo Yeon Yoon, Sang Chul Lee, Young-sil An & Yong Wook Kim. (2020) Neural correlates and gait characteristics for hypoxic-ischemic brain injury induced freezing of gait. Clinical Neurophysiology 131:1, pages 46-53.
Crossref
Crossref
Tamaya Van Criekinge, Kristiaan D’Août, Jonathon O’Brien & Eduardo Coutinho. (2019) Effect of music listening on hypertonia in neurologically impaired patients—systematic review. PeerJ 7, pages e8228.
Crossref
Crossref
K.-Alexander Engelhardt, Philine Marchetta, Rainer K. W. Schwarting & Liana Melo-Thomas. (2018) Haloperidol–induced catalepsy is ameliorated by deep brain stimulation of the inferior colliculus. Scientific Reports 8:1.
Crossref
Crossref
Kiminobu Sugaya & Manjusha Vaidya. 2018. Exosomes, Stem Cells and MicroRNA. Exosomes, Stem Cells and MicroRNA
61
84
.
Seo Yeon Yoon, Sang Chul Lee, Na Young Kim, Young-Sil An & Yong Wook Kim. (2017) Brain metabolism in patients with freezing of gait after hypoxic-ischemic brain injury. Medicine 96:45, pages e8212.
Crossref
Crossref
Maria-Rosario Luquin, Jaime Kulisevsky, Pablo Martinez-Martin, Pablo Mir & Eduardo S. Tolosa. (2017) Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study). Parkinson's Disease 2017, pages 1-8.
Crossref
Crossref
C. Gentil, A.-L. Esnault, T. Danaila, E. Broussolle & S. Thobois. (2016) L’intervention orthophonique dans la maladie de Parkinson. Pratique Neurologique - FMC 7:4, pages 256-265.
Crossref
Crossref
Reversa Mills, Laxman Bahroo & Fernando Pagan. (2014) An Update on the Use of Botulinum Toxin Therapy in Parkinson’s Disease. Current Neurology and Neuroscience Reports 15:1.
Crossref
Crossref
Lars B. Oude Nijhuis, John H. J. Allum, Wandana Nanhoe-Mahabier & Bastiaan R. Bloem. (2014) Influence of Perturbation Velocity on Balance Control in Parkinson’s Disease. PLoS ONE 9:1, pages e86650.
Crossref
Crossref
Mark Slifstein, Eugenii A. Rabiner & Roger N. Gunn. 2014. Imaging of the Human Brain in Health and Disease. Imaging of the Human Brain in Health and Disease
265
287
.
Raja Mehanna & Joseph Jankovic. 2014. Handbook of Neurotoxicity. Handbook of Neurotoxicity
553
590
.
Boris Takač, Andreu Català, Daniel Rodríguez Martín, Nico van der Aa, Wei Chen & Matthias Rauterberg. (2013) Position and Orientation Tracking in a Ubiquitous Monitoring System for Parkinson Disease Patients With Freezing of Gait Symptom. JMIR mhealth and uhealth 1:2, pages e14.
Crossref
Crossref
Johan LökkSeyed-Mohammad Fereshtehnejad. (2013) Managing palliative care in Parkinson’s disease from diagnosis to end-stage disease: what the clinician should know. Neurodegenerative Disease Management 3:2, pages 169-183.
Crossref
Crossref
Johan Lokk & Ahmad Delbari. (2012) Clinical aspects of palliative care in advanced Parkinson’s disease. BMC Palliative Care 11:1.
Crossref
Crossref
J.M. Shine, S.L. Naismith & S.J.G. Lewis. (2011) The pathophysiological mechanisms underlying freezing of gait in Parkinson’s Disease. Journal of Clinical Neuroscience 18:9, pages 1154-1157.
Crossref
Crossref
Patrick M. Schweder, Peter C. Hansen, Alex L. Green, Gerardine Quaghebeur, John Stein & Tipu Z. Aziz. (2010) Connectivity of the pedunculopontine nucleus in parkinsonian freezing of gait. NeuroReport 21:14, pages 914-916.
Crossref
Crossref
Sharon L. Naismith & Simon J.G. Lewis. (2010) A novel paradigm for modelling freezing of gait in Parkinson’s disease. Journal of Clinical Neuroscience 17:8, pages 984-987.
Crossref
Crossref
Sharon L. Naismith, James M. Shine & Simon J.G. Lewis. (2010) The specific contributions of set‐shifting to freezing of gait in Parkinson's disease. Movement Disorders 25:8, pages 1000-1004.
Crossref
Crossref
Joseph Jankovic. (2009) Disease-oriented approach to botulinum toxin use. Toxicon 54:5, pages 614-623.
Crossref
Crossref
Simon J.G. Lewis & Roger A. Barker. (2009) A pathophysiological model of freezing of gait in Parkinson's disease. Parkinsonism & Related Disorders 15:5, pages 333-338.
Crossref
Crossref
Simon J.G. Lewis & Roger A. Barker. (2009) Understanding the dopaminergic deficits in Parkinson’s disease: Insights into disease heterogeneity. Journal of Clinical Neuroscience 16:5, pages 620-625.
Crossref
Crossref
Susan E. Langmore, Gregory Grillone, Alphi Elackattu & Michael Walsh. (2009) Disorders of Swallowing: Palliative Care. Otolaryngologic Clinics of North America 42:1, pages 87-105.
Crossref
Crossref
Malcolm Lader. (2008) Antiparkinsonian Medication and Pathological Gambling. CNS Drugs 22:5, pages 407-416.
Crossref
Crossref
Laura Gomide, Arthur Kummer, Francisco Cardoso & Antonio Lucio Teixeira. (2008) Use of clozapine in Brazilian patients with Parkinson's disease. Arquivos de Neuro-Psiquiatria 66:3b, pages 611-614.
Crossref
Crossref
Alan Diamond, Christopher Kenney, Michael Almaguer & Joseph Jankovic. (2007) Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Journal of Neurosurgery 107:5, pages 1036-1038.
Crossref
Crossref
Alan Diamond, Christopher Kenney, Michael Almaguer & Joseph Jankovic. (2007) Hyperhidrosis due to deep brain stimulation in a patient with essential tremor. Journal of Neurosurgery 107:5, pages 1036-1038.
Crossref
Crossref
K.S. Rommelfanger & D. Weinshenker. (2007) Norepinephrine: The redheaded stepchild of Parkinson's disease. Biochemical Pharmacology 74:2, pages 177-190.
Crossref
Crossref
Jyh-Gong Gabriel Hou & Eugene C Lai. (2007) Non-motor Symptoms of Parkinson's Disease. International Journal of Gerontology 1:2, pages 53-64.
Crossref
Crossref
Joseph Jankovic & Mark Stacy. (2007) Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson???s Disease. CNS Drugs 21:8, pages 677-692.
Crossref
Crossref
Amitabh Gupta & Ted M. Dawson. (2007) The Role of Stem Cells in Parkinson's Disease. Neurosurgery Clinics of North America 18:1, pages 129-142.
Crossref
Crossref